73 related articles for article (PubMed ID: 2026883)
1. Priming for in vitro and in vivo anti-human T lymphotropic virus type 1 cellular immunity by virus-related protein reconstituted into liposome.
Noguchi Y; Noguchi T; Sato T; Yokoo Y; Itoh S; Yoshida M; Yoshiki T; Akiyoshi K; Sunamoto J; Nakayama E
J Immunol; 1991 May; 146(10):3599-603. PubMed ID: 2026883
[TBL] [Abstract][Full Text] [Related]
2. Rat cytotoxic T lymphocytes against human T-lymphotropic virus type 1-infected cells recognize gag gene and env gene encoded antigens.
Noguchi Y; Tateno M; Kondo N; Yoshiki T; Shida H; Nakayama E; Shiku H
J Immunol; 1989 Dec; 143(11):3737-42. PubMed ID: 2479689
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of human T cell leukemia virus type-I (HTLV-I) antigens for cytotoxic T lymphocytes in the rat system.
Tanaka Y; Isobe A; Masuda M; Tozawa H; Koyanagi Y; Yamamoto N; Shida H
J Immunol; 1991 Nov; 147(10):3646-52. PubMed ID: 1940363
[TBL] [Abstract][Full Text] [Related]
4. Recognition of human T cell leukemia virus type I (HTLV-I) gag and pX gene products by MHC-restricted cytotoxic T lymphocytes induced in rats against syngeneic HTLV-I-infected cells.
Tanaka Y; Tozawa H; Koyanagi Y; Shida H
J Immunol; 1990 Jun; 144(11):4202-11. PubMed ID: 2187927
[TBL] [Abstract][Full Text] [Related]
5. Rapid syncytium formation between human T-cell leukaemia virus type-I (HTLV-I)-infected T-cells and human nervous system cells: a possible implication for tropical spastic paraparesis/HTLV-I associated myelopathy.
Mor-Vaknin N; Turgeman H; Torgeman A; Wolfson M; Huleihel M; Aboud M
Cell Biol Int; 1998; 22(2):95-103. PubMed ID: 9878096
[TBL] [Abstract][Full Text] [Related]
6. Clonal expansion of CD8+ cytotoxic T lymphocytes against human T cell lymphotropic virus type I (HTLV-I) genome products in HTLV-I-associated myelopathy/tropical spastic paraparesis patients.
Furukawa K; Mori M; Ohta N; Ikeda H; Shida H; Furukawa K; Shiku H
J Clin Invest; 1994 Nov; 94(5):1830-9. PubMed ID: 7962528
[TBL] [Abstract][Full Text] [Related]
7. Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.
Kuroki M; Nakamura M; Itoyama Y; Tanaka Y; Shiraki H; Baba E; Esaki T; Tatsumoto T; Nagafuchi S; Nakano S
J Immunol; 1992 Aug; 149(3):940-8. PubMed ID: 1378869
[TBL] [Abstract][Full Text] [Related]
8. Immune recognition of human T-cell leukemia virus type-I (HTLV-I) by MHC-restricted cytotoxic T lymphocytes.
Tanaka Y
Kitasato Arch Exp Med; 1992 Sep; 65(2-3):79-85. PubMed ID: 1308259
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and protective efficacy of recombinant human T-cell leukemia/lymphoma virus type 1 NYVAC and naked DNA vaccine candidates in squirrel monkeys (Saimiri sciureus).
Kazanji M; Tartaglia J; Franchini G; de Thoisy B; Talarmin A; Contamin H; Gessain A; de Thé G
J Virol; 2001 Jul; 75(13):5939-48. PubMed ID: 11390595
[TBL] [Abstract][Full Text] [Related]
10. Efficient induction of human T-cell leukemia virus-1-specific CTL by chimeric particle without adjuvant as a prophylactic for adult T-cell leukemia.
Kozako T; Fukada K; Hirata S; White Y; Harao M; Nishimura Y; Kino Y; Soeda S; Shimeno H; Lemonnier F; Sonoda S; Arima N
Mol Immunol; 2009 Dec; 47(2-3):606-13. PubMed ID: 19889459
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a HTLV-1 subunit vaccine in prevention of experimental STLV-I infection in Macaca nemestrina.
Dezzutti CS; Frazier DE; Lafrado LJ; Olsen RG
J Med Primatol; 1990; 19(3-4):305-16. PubMed ID: 2172541
[TBL] [Abstract][Full Text] [Related]
12. Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model.
Earl PL; Wyatt LS; Montefiori DC; Bilska M; Woodward R; Markham PD; Malley JD; Vogel TU; Allen TM; Watkins DI; Miller N; Moss B
Virology; 2002 Mar; 294(2):270-81. PubMed ID: 12009868
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
Deml L; Schirmbeck R; Reimann J; Wolf H; Wagner R
Virology; 1997 Aug; 235(1):26-39. PubMed ID: 9300034
[TBL] [Abstract][Full Text] [Related]
14. Identification of HTLV-1-specific CTL directed against synthetic and naturally processed peptides in HLA-B*3501 transgenic mice.
Schönbach C; Nokihara K; Bangham CR; Kariyone A; Karaki S; Shida H; Takatsu K; Egawa K; Wiesmüller KH; Takiguchi M
Virology; 1996 Dec; 226(1):102-12. PubMed ID: 8941327
[TBL] [Abstract][Full Text] [Related]
15. Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs.
Shirai M; Pendleton CD; Ahlers J; Takeshita T; Newman M; Berzofsky JA
J Immunol; 1994 Jan; 152(2):549-56. PubMed ID: 8283036
[TBL] [Abstract][Full Text] [Related]
16. Human Dlg protein binds to the envelope glycoproteins of human T-cell leukemia virus type 1 and regulates envelope mediated cell-cell fusion in T lymphocytes.
Blot V; Delamarre L; Perugi F; Pham D; Bénichou S; Benarous R; Hanada T; Chishti AH; Dokhélar MC; Pique C
J Cell Sci; 2004 Aug; 117(Pt 17):3983-93. PubMed ID: 15286176
[TBL] [Abstract][Full Text] [Related]
17. Human T-cell leukemia virus type-I (HTLV-I)-specific T-cell responses detected using three-divided glutathione-S-transferase (GST)-Tax fusion proteins.
Kurihara K; Shimizu Y; Takamori A; Harashima N; Noji M; Masuda T; Utsunomiya A; Okamura J; Kannagi M
J Immunol Methods; 2006 Jun; 313(1-2):61-73. PubMed ID: 16723135
[TBL] [Abstract][Full Text] [Related]
18. Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo.
Böhm W; Schirmbeck R; Elbe A; Melber K; Diminky D; Kraal G; van Rooijen N; Barenholz Y; Reimann J
J Immunol; 1995 Oct; 155(7):3313-21. PubMed ID: 7561024
[TBL] [Abstract][Full Text] [Related]
19. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease.
Jacobson S; Shida H; McFarlin DE; Fauci AS; Koenig S
Nature; 1990 Nov; 348(6298):245-8. PubMed ID: 2146511
[TBL] [Abstract][Full Text] [Related]
20. Anti-Gag cytolytic T lymphocytes specific for an alternative translational reading frame-derived epitope and resistance versus susceptibility to retrovirus-induced murine AIDS in F(1) mice.
Mayrand SM; Healy PA; Torbett BE; Green WR
Virology; 2000 Jul; 272(2):438-49. PubMed ID: 10873788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
